Is the yellow fever vaccine a live‑attenuated vaccine and can it be administered concurrently with inactivated vaccines such as Tdap and IPV?

Yellow Fever Vaccine: Live-Attenuated Formulation and Concurrent Administration

Yes, the yellow fever vaccine is a live-attenuated virus vaccine made from the 17D strain, and it can be safely administered simultaneously with inactivated vaccines such as Tdap and IPV using separate syringes at different injection sites. 1, 2

Vaccine Composition and Mechanism

The yellow fever vaccine is definitively a live, attenuated virus preparation derived from the 17D yellow fever virus strain, grown in chick embryos. 1 This live vaccine works by:

• Infecting cells at the injection site with limited viral replication and spread 3
• Producing a brief, low-level viremia that resolves within 4-7 days as neutralizing antibodies develop 4, 5
• Generating an immune response identical in quality to wild-type yellow fever infection 3

The 17D-204 strain (YF-VAX®) is used in the United States, while the 17DD strain is used in Brazil; both share 99.9% sequence homology and have identical safety and immunogenicity profiles. 1, 3

Concurrent Administration with Inactivated Vaccines

Inactivated vaccines can be administered either simultaneously or at any time before or after yellow fever vaccination without interference. 2 This explicitly includes:

• Tdap (tetanus-diphtheria-pertussis) - Studies confirm no immune interference when given with yellow fever vaccine 2
• IPV (inactivated polio vaccine) - Can be administered simultaneously without affecting immune response 2
• Other inactivated vaccines: hepatitis A, hepatitis B, influenza, meningococcal (Menomune), and injectable typhoid 2

Administration Protocol

When giving vaccines concomitantly:

• Use separate syringes for each vaccine 3
• Administer at separate anatomic sites 3
• Never combine or mix yellow fever vaccine with any other vaccine 3

Critical Timing Considerations for Live Vaccines

Yellow fever vaccine must be administered either simultaneously or at least 30 days apart from other live viral vaccines because the immune response to one live virus vaccine may be impaired if given within 30 days of another. 2 The exception is oral Ty21a typhoid vaccine, which can be given at any interval due to different routes of administration. 2

Live Vaccines Requiring 30-Day Separation (if not given simultaneously):

• MMR (measles-mumps-rubella)
• Varicella
• Zoster
• Live-attenuated influenza

Important Clinical Caveats

Tuberculin Skin Test Interaction

Because live-attenuated vaccines can theoretically suppress tuberculin skin test (TST) reactivity:

• Administer TST at the same time as yellow fever vaccine, OR
• Perform TST at least 4 weeks after yellow fever vaccination 2
• If yellow fever vaccine was recently given, delay TST screening for at least 4 weeks 2

No Interference with Antimalarials or Immune Globulin

• Chloroquine does not adversely affect antibody responses to yellow fever vaccine despite inhibiting viral replication in vitro 2
• Immune globulin administered simultaneously does not alter immunologic response to yellow fever vaccine 2

Absolute Contraindications (Due to Live-Attenuated Nature)

The live nature of this vaccine creates specific contraindications:

• Infants <6 months - Risk of vaccine-associated neurotropic disease (50-400 cases per 100,000) 2, 6
• Severe immunosuppression - CD4 <200/mm³, primary immunodeficiencies, malignancies, transplant recipients 6, 5
• Immunosuppressive medications - High-dose corticosteroids (≥20 mg/day prednisone for ≥2 weeks), alkylating drugs, antimetabolites, TNF-α inhibitors 2, 5
• Thymus disorders with abnormal immune function (thymoma, myasthenia gravis) 6

Exception for Incidental Thymectomy

Individuals who underwent incidental surgical thymus removal (e.g., during cardiac surgery) are not considered immunocompromised and can receive yellow fever vaccine without restriction, as they maintain adequate immune function through peripheral T-cell populations. 6

Practical Algorithm for Vaccination Scheduling

For patients requiring both yellow fever vaccine and inactivated vaccines (Tdap, IPV):

1. Preferred approach: Administer all vaccines simultaneously at separate sites with separate syringes 2, 3
2. If not simultaneous: Give inactivated vaccines at any interval before or after yellow fever vaccine (no waiting period required) 2

For patients requiring yellow fever vaccine and other live vaccines:

1. Preferred approach: Administer simultaneously at separate sites 2
2. If not simultaneous: Wait at least 30 days between yellow fever vaccine and other live vaccines 2

For immunocompromised patients:

1. Do not vaccinate - provide medical waiver letter 6, 5
2. Emphasize mosquito-bite prevention measures 5
3. Never vaccinate solely to meet administrative travel requirements when contraindication exists 5